Coldstream Capital Management Inc Krystal Biotech, Inc. Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 556 shares of KRYS stock, worth $90,233. This represents 0.0% of its overall portfolio holdings.
Number of Shares
556Holding current value
$90,233% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding KRYS
# of Institutions
312Shares Held
23.8MCall Options Held
257KPut Options Held
170K-
Black Rock Inc. New York, NY3.95MShares$641 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.83MShares$459 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.73MShares$443 Million7.97% of portfolio
-
State Street Corp Boston, MA1.23MShares$199 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA954KShares$155 Million0.03% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $4.17B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...